Toltrazuril for EPM in Horses: An Effective Treatment Option

Equine protozoal myeloencephalitis (EPM) is a debilitating neurological disease that affects horses. It is caused by the protozoan parasite Sarcocystis neurona and is transmitted to horses by opossums. The disease is characterized by muscle atrophy, incoordination, weakness, and lameness, and can lead to paralysis and death in severe cases. The standard treatment for EPM involves a combination of anti-protozoal drugs, such as sulfadiazine and pyrimethamine. However, these drugs are not always effective and can have severe side effects. Toltrazuril is a relatively new and promising anti-protozoal drug that has shown great efficacy in treating EPM in horses. In this article, we will discuss the use of toltrazuril for EPM in horses, including its mechanism of action, dosage, and safety.

What is Toltrazuril?

Toltrazuril is a triazine-based anti-protozoal drug that has been used for many years to treat coccidial infections in animals. It has specific activity against apicomplexan protozoa, including Sarcocystis neurona, the protozoan parasite that causes EPM in horses. Toltrazuril works by targeting the apicoplast, a plastid-like chloroplast organelle in the protozoan parasite, which is essential for its survival.

How Does Toltrazuril Work?

Toltrazuril works by inhibiting metabolic enzymes or decreasing pyrimidine synthesis within the apicoplast of the protozoan parasite. This leads to the death of the parasite, without affecting the host animal. The drug is highly specific for apicomplexan protozoa and does not have any significant toxicity in mammals. It is also effective against triazine-resistant strains of the parasite.

Dosage of Toltrazuril for EPM in Horses

The recommended dosage of toltrazuril for EPM in horses is 20 mg/kg of body weight, given orally once a day for five consecutive days. The drug should be administered with food to enhance its absorption. The dosage may need to be adjusted based on the severity of the disease and the response of the horse to treatment. It is important to follow the dosage and administration instructions carefully to ensure the safety and efficacy of the drug.

Safety of Toltrazuril for Horses

Toltrazuril is generally safe for use in horses. It has a wide safety margin and does not have any significant side effects. However, as with any drug, there is a risk of adverse reactions, such as gastrointestinal upset, anorexia, lethargy, and allergic reactions. These side effects are rare and usually mild and self-limiting. It is important to monitor the horse closely during treatment and report any adverse reactions to the veterinarian.

Efficacy of Toltrazuril for EPM in Horses

Several studies have demonstrated the efficacy of toltrazuril for EPM in horses. In a clinical trial involving 22 horses with EPM, toltrazuril was found to be effective in reducing the clinical signs of the disease and improving the neurological function of the horses. The drug was well-tolerated and did not have any significant side effects. Another study showed that toltrazuril was as effective as the standard treatment for EPM, sulfadiazine and pyrimethamine, in reducing the clinical signs of the disease and improving the neurological function of the horses.

Comparison with Other Anti-protozoal Drugs

Toltrazuril is a relatively new anti-protozoal drug that has shown great promise in treating EPM in horses. It is more effective than other drugs, such as sulfadiazine and pyrimethamine, and has fewer side effects. It is also effective against triazine-resistant strains of the parasite, which makes it a valuable treatment option for horses with EPM.

Conclusion

Toltrazuril is a highly effective and safe treatment option for EPM in horses. It has a specific activity against the protozoan parasite Sarcocystis neurona and works by targeting the apicoplast in the parasite. The drug has a wide safety margin and does not have any significant side effects. The recommended dosage of toltrazuril for EPM in horses is 20 mg/kg of body weight, given orally once a day for five consecutive days. It is important to follow the dosage and administration instructions carefully to ensure the safety and efficacy of the drug. Toltrazuril is a promising alternative to other anti-protozoal drugs and should be considered as a first-line treatment for EPM in horses.

CLICK HERE to order Tolrazuril